⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11922701 | 1.00 | — | — | |
| SCHEMBL14038199 | 1.00 | — | — | |
| SCHEMBL14140837 | 1.00 | — | — | |
| SCHEMBL10314790 | 0.88 | — | — | |
| SCHEMBL19884722 | 0.84 | — | — | |
| SCHEMBL15145021 | 0.77 | — | — | |
| SCHEMBL12175421 | 0.73 | — | — | |
| SCHEMBL13853062 | 0.73 | — | — | |
| SCHEMBL24059954 | 0.72 | — | — | |
| SCHEMBL18025439 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3235817-A1 | LACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASES AND CONDITIONS | Cayman Chemical Company, Incorporated (US) | 2017-10-25 | — | — | EP | disclosed |
| WO-2017165878-A1 | CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2017-09-28 | — | — | WO | disclosed |
| US-20150266839-A1 | CYCLIC AMIDE DERIVATIVE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| US-20150225392-A1 | CYCLIC AMIDE DERIVATIVE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2015-08-13 | — | — | US | disclosed |
| US-9072758-B2 | Cyclic amide derivative | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2015-07-07 | — | — | US | disclosed |
| US-9040525-B2 | Cyclic amide derivative | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2015-05-26 | — | — | US | disclosed |
| US-8765752-B2 | 3-hydroxyisothiazole 1-oxide derivatives | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2014-07-01 | — | — | US | disclosed |
| EP-2703394-A1 | NOVEL 3-HYDROXYISOTHIAZOLE 1-OXIDE DERIVATIVE | Mochida Pharmaceutical Co., Ltd. (JP) | 2014-03-05 | — | — | EP | disclosed |
| EP-2703393-A1 | CYCLIC AMIDE DERIVATIVE | Mochida Pharmaceutical Co., Ltd. (JP) | 2014-03-05 | — | — | EP | disclosed |
| US-20140057871-A1 | CYCLIC AMIDE DERIVATIVE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2014-02-27 | — | — | US | disclosed |
| US-20120220772-A1 | NOVEL 3-HYDROXY-5-ARYLISOXAZOLE DERIVATIVE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2012-08-30 | — | — | US | disclosed |
| US-20120157459-A1 | NOVEL 3-HYDROXY-5-ARYLISOTHIAZOLE DERIVATIVE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20120098047-A1 | GETTERING AGENTS IN MEMORY CHARGE STORAGE STRUCTURES | MICRON TECHNOLOGY, INC. | 2012-04-26 | — | — | US | disclosed |
| EP-2423201-A1 | Luminescent macrocyclic lanthanide complexes | The Regents of The University of California (US) | 2012-02-29 | — | — | EP | disclosed |
| US-20120012160-A1 | SOLAR MODULE STRUCTURES AND ASSEMBLY METHODS FOR PYRAMIDAL THREE-DIMENSIONAL THIN-FILM SOLAR CELLS | SOLEXEL INC. (US) | 2012-01-19 | — | — | US | disclosed |
| EP-2380849-A1 | HYDROGEN GENERATOR, FUEL CELL SYSTEM, AND METHOD OF STOPPING HYDROGEN GENERATOR | Panasonic Corporation (JP) | 2011-10-26 | — | — | EP | disclosed |
| US-7678454-B2 | Method for forming finely-structured parts, finely-structured parts formed thereby, and product using such finely-structured part | NEC CORPORATION (JP) | 2010-03-16 | — | — | US | disclosed |
| US-20090298151-A1 | HYDROGEN PRODUCING MICROORGANISM USEFUL FOR ENERGY GENERATION FROM DIVERSE CARBONACEOUS FEEDSTOCK | DR. ELMAR SCHMID AND JAMES GIBSON (US) | 2009-12-03 | — | — | US | disclosed |
| WO-2009055331-A2 | BICYCLIC HETEROCYCLE DERIVATIVES AND THEIR USE AS MODULATORS OF THE ACTIVITY OF GPR119 | SCHERING CORPORATION (US) | 2009-04-30 | — | — | WO | disclosed |
| EP-2034018-A1 | GENETICALLY MODIFIED ANIMAL AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2009-03-11 | — | — | EP | disclosed |